A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade
Open Access
- 14 September 2020
- journal article
- editorial
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 106 (2), 651-654
- https://doi.org/10.3324/haematol.2020.258426
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- PD-L1 Status in Refractory LymphomasPLOS ONE, 2016
- Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib StudyJournal of Clinical Oncology, 2016
- Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic MalignanciesThe Journal of Molecular Diagnostics, 2016
- Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep SequencingClinical Cancer Research, 2015
- High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)Leukemia, 2015
- Comparison of Whole Blood and Peripheral Blood Mononuclear Cell Gene Expression for Evaluation of the Perioperative Inflammatory Response in Patients with Advanced Heart FailurePLOS ONE, 2014
- Detecting ultralow-frequency mutations by Duplex SequencingNature Protocols, 2014
- Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteriaLeukemia, 2007
- Predominant Hematopoietic Origin of Cell-free DNA in Plasma and Serum after Sex-mismatched Bone Marrow TransplantationClinical Chemistry, 2002
- Lymph Node Involvement by Splenic Marginal Zone Lymphoma: Morphological and Immunohistochemical FeaturesThe American Journal of Surgical Pathology, 1997